Laurus Labs is Indian pharma’s dark horse
With a promoter who is unafraid to make bold bets and pivot to businesses holding more promise, investors can only look forward to better times.
21 December, 2023•7 min
0
21 December, 2023•7 min
0
Getting your Trinity Audio player ready...
More in Business
Business
Sunil Mittal wants to create another Bajaj Finance. Can he?
Bharti Airtel’s ambitious plan for Airtel Money is a result of excess cash. The NBFC’s success will depend on how the parent battles the formidable rivals and India’s data privacy regulations.
You may also like
Business
Wockhardt urgently needs Rs 400 crore and its two wonder drugs
A couple of antibiotics that have the potential to change the beleaguered company’s fortunes need a quick infusion of funds to get across the finish line. Can Khorakiwala, the 82-year-old chairman, pull it off?
Business
Has Aurobindo Pharma left its wild swings behind?
The Hyderabad-based generics maker has seen its stock scale all-time highs and lows in quick succession. With big plans in place and regulatory heat easing, its roller-coaster days may be over.
Business
Is the Cipla play Torrent Pharma’s cowboy moment?
The quiet, conservative Ahmedabad-based drug maker is ready to pledge family silver to acquire a rival many times its size. The question is whether it can survive its ambition.